Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924006396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of refractory cold agglutinin syndrome using fixed duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge
by: Brad Rybinski, et al.
Published: (2025-05-01) -
Daratumumab for refractory posttransplant autoimmune hemolytic anemia: An option beyond the obvious
by: Sreedhar Jayakrishnan Cherulil, et al.
Published: (2025-01-01) -
Paudel BB, Tan S-F, Fox TE, et al. Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes. Blood Adv. 2024;8(5):1137-1142.
Published: (2025-05-01) -
Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023
by: Sylvie Bozzi, et al.
Published: (2025-01-01) -
Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.
by: Sylvie Bozzi, et al.
Published: (2025-01-01)